FDA Clearance Tracker · K180237
Rezum System
Last checked: Nov 19, 2026Latest source record: Feb 27, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2018
Substantially Equivalent
Time to decision
29 days
Received Jan 29, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K180237
- Device name
- Rezum System
- Applicant
- Nxthera, Inc.
- Applicant location
- Maple Grove, MN
- Received
- Jan 29, 2018
- Decided
- Feb 27, 2018
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.4300
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KNS. The earliest in FDA's data is K760178, decided Oct 15, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K180237
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Nxthera, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Rezum System510(k)
K160417 · Decided Mar 17, 2016 · 30 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
- Rezum System510(k)
K150786 · Decided Aug 27, 2015 · 155 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.